Summary
The effect of tricyclic antidepressant drugs on the deamination of phenylethylamine and benzylamine by monoamine oxidase (MAO) type B was investigated in vitro in human brain cortex, human platelet, and rat brain preparations. These drugs inhibited MAO activity as expected; however, an atypical biphasic response was observed with the tertiary amine tricyclic, clomipramine, and, to a somewhat lesser extent, with two other tertiary amine tricyclics, imipramine and amitriptyline, when benzylamine was used as the substrate in human tissue preparations. This atypical biphasic pattern was not found when we used the secondary amine antidepressant drugs, desipramine, desmethylclomipramine, or fluoxetine, or used phenylethylamine as the substrate, or used rat rather than human brain tissue. For the tricyclics exhibiting normal inhibition patterns, the same rank order of inhibition was observed with benzylamine as a substrate in all three types of tissue; however with phenylethylamine, differences in inhibition were found between rat and human tissues. These tricyclic-MAO interactional data suggest that secondary and tertiary amine tricyclics interact differently with human MAO type B, that rat and human MAO type B are not functionally identical, and also support other data that phenylethylamine and benzylamine are deaminated by different mechanisms.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Benfield DP, Harries CM, Luscombe DK (1980) Some pharmacological aspects of desmethylclomipramine. Postgrad Med J 56:13–18
Carlsson A, Fuxe K, Ungerstedt U (1968) The effect of imipramine on central 5-hydroxytryptamine neurons. J Pharm Pharmacol 20:150–151
Carlsson A, Corrodi H, Fuxe K, Hokfelt T (1969) Effects of some antidepressant drugs on the depletion of intraneuronal brain catecholamine stores caused by 4-alpha-dimethyl-metatyramine. Eur J Pharmacol 5:367–373
Denney RM, Patel NT, Fritz RR, Abell CW (1982) A monoclonal antibody elicited to human platelet monoamine oxidase. Isolation and specificity for human monoamine oxidase B but not A. Mol Pharmacol 22:500–508
Denney RM, Fritz RR, Patel NT, Widen SG, Abell CW (1983) Use of a monoclonal antibody for comparative studies of monoamine oxidase B in mitochondrial extracts of human brain and peripheral tissues. Mol Pharmacol 24:60–68
Denney RM, Denney CB (1985) An update on the identity crisis of monoamine oxidase: new and old evidence for the independency of MAO A and B. Pharmacol Ther 30:227–259
Donnelly CH, Murphy DL (1977) Substrate- and inhibitor-related characteristics of human platelet monoamine oxidase. Biochem Pharmacol 26:853–858
Edwards DJ, Burns MO (1974) Effects of tricyclic antidepressants upon human platelet monoamine oxidase. Life Sci 15:2045–2058
Edwards DJ, Chang SS (1975) Evidence for interacting catalytic sites of human platelet monoamine oxidase. Biochem Biophys Res Comm 65:1018–1025
Fowler CJ, Ekstedt B, Egashira T, Kinemucbi H, Oreland L (1979) The interaction between human platelet monoamine oxidase, its monoamine substrates and oxygen. Biochem Pharmacol 28:3063–3068
Fowler CJ, Wiberg A, Oreland L, Winblad B (1980) Titration of human brain type-B monoamine oxidase. Neurochem Res 5:697–708
Garrick NA, Murphy DL (1982) Monoamine oxidase type A: differences in selectivity towards l-norepinephrine compared to serotonin. Biochem Pharmacol 31:4061–4066
Garrick NA, Redmond DE, Murphy DL (1979) Primate-rodent monoamine oxidase differences. In: Singer TP, Von Korff RW, Murphy DL (eds) Monoamine oxidase: structure, function, and altered functions. Academic Press, New York, pp 351–359
Glowinski J, Axelrod J (1966) Effects of drugs on the disposition of 3H-norepinephrine in the rat brain. Pharmacol Rev 18:775–785
Hall DWR, Logan BW, Parsons GH (1969) Further studies on the inhibition of monoamine oxidase by M and B 9302 (clorgyline). I. Substrate specificity in various mammalian species. Biochem Pharmacol 18:1447–1454
Houslay MD, Tipton KF (1976) Multiple forms of monoamine oxidase: fact and artefact. Life Sci 19:467–478
Johnston JP (1968) Some observations upon a new inhibition of monoamine oxidase in brain tissue. Biochem Pharmacol 17:1285–1297
Kobayashi K, Kohsaka M, Eiduson S (1979) Effect of temperature on human platelet monoamine oxidase. Biochem Med 22:59–63
Lowry OH, Rosebrough JJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275
Murphy DL, Wright C, Buchsbaum M, Nichols A, Costa JL, Wyatt RJ (1976) Platelet and plasma amine oxidase activity in 680 normals: sex and age differences and stability over time. Biochem Med 16:254–265
Pearce LB, Roth JA (1985) Human brain monoamine oxidase type B: mechanism of deamination as probed by steady-state methods. Biochemistry 24:1821–1826
Preskorn SH (1986) Tricyclic antidepressant plasma level monitoring: an improvement over the dose-response approach. J Clin Psych 47:24–30
Roth JA (1976a) Multiple forms of monoamine oxidase and their interaction with tricyclic psychomimetic drugs. Gen Pharmacol 7:381–386
Roth JA (1976b) Evidence for a single catalytic binding site on human brain type B monoamine oxidase. J Neurochem 27:1107–1112
Roth JA (1978) Inhibition of human brain type B monoamine oxidase by tricyclic psychoactive drugs. Mol Pharmacol 14:164–171
Roth JA (1979) Effect of drugs on inhibition of oxidized and reduced form of MAO. In: Singer TP, Von Korff RW, Murphy DL (eds) Monoamine oxidase: structure, function, and altered functions. Academic Press, New York, pp 153–168
Shaskan EG, Snyder SH (1970) Kinetics of serotonin accumulation into slices from rat brain: relationship to catecholamine uptake. J Pharmacol Exp Ther 175:404–418
Sheard MH, Zolovick A, Aghajanian GK (1972) Raphe neurons: effect of tricyclic antidepressant drugs. Brain Res 43:690–694
Squires RF (1972) Multiple forms of monoamine oxidase in intact mitochondria as characterized by selective inhibitors and thermal stability: a comparison of eight mammalian species. In: Costa E, Greengard P (eds) Advances in biochemical psychopharmacology, vol 5. Raven Press, New York, pp 355–370
Young Jr WF, Laws Jr ER, Sharbrough FW, Weinshilboum RM (1986) Human monoamine oxidase: lack of brain and platelet correlation. Arch Gen Psychiatry 43:604–609
Yu PH, Boulton AA (1979) Activation of platelet monoamine oxidase by plasma in the human. Life Sci 25:31–36
Author information
Authors and Affiliations
Additional information
Send offprint requests to A. A. Reid at the above address
Rights and permissions
About this article
Cite this article
Reid, A.A., Hill, J.L. & Murphy, D.L. Interactions of tricyclic antidepressant drugs with human and rat monoamine oxidase type B. Naunyn-Schmiedeberg's Arch Pharmacol 338, 678–683 (1988). https://doi.org/10.1007/BF00165634
Issue Date:
DOI: https://doi.org/10.1007/BF00165634